Menu
Menu
Fischer Medical Ventures’ subsidiary, Time Medical International Ventures, has received the CDSCO license to manufacture MRI systems in India. This groundbreaking achievement supports the "Make in India" initiative, boosts local production of high-quality medical devices, and enhances access to advanced diagnostic technology in India and beyond.
Cipla and Alkem Laboratories are poised to acquire a controlling stake in Sahajanand Medical Technologies, India's leading cardiac stent manufacturer, with a deal valued between Rs 3,500 and Rs 4,000 crore. As major private equity firms step back, this acquisition could reshape the competitive landscape of the expanding cardiac stent market. The Kotadia family plans to retain a minority stake, while SMT explores IPO options following a pause in its previous listing plans. Dive into the details of this high-stakes negotiation and its potential impact on the future of cardiac care in India